Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Pill Club was a U.S. women's health telemedicine and pharmacy company focused on online prescribing and home delivery of birth control, along with related services such as emergency contraception, skincare, menstrual care, and later broader primary care offerings. The business operated a vertically integrated model combining digital intake, clinical review, prescription fulfillment, and mail-order pharmacy services. The company rebranded to Favor during its expansion beyond contraception, but the original Pill Club brand remained widely recognized. In 2023, the business entered Chapter 11 bankruptcy, and key assets and patient relationships were subsequently transferred through a continuity-of-care transaction tied to Thirty Madison's Nurx platform. As a result, The Pill Club should be viewed primarily as a defunct/acquired women's health telehealth brand rather than an operating independent biotech or pharma developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Pill Club.